BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23377337)

  • 1. Clearance of invasive melanoma with topical imiquimod.
    Moon SD; Spencer JM
    J Drugs Dermatol; 2013 Jan; 12(1):107-8. PubMed ID: 23377337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using topical imiquimod for the management of positive in situ margins after melanoma resection.
    Pandit AS; Geiger EJ; Ariyan S; Narayan D; Choi JN
    Cancer Med; 2015 Apr; 4(4):507-12. PubMed ID: 25620351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subungual Melanoma In Situ Treated With Imiquimod 5% Cream After Conservative Surgery Recurrence.
    Ocampo-Garza J; Gioia Di Chiacchio N; Haneke E; le Voci F; Paschoal FM
    J Drugs Dermatol; 2017 Mar; 16(3):268-270. PubMed ID: 28301623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod clears invasive melanoma.
    Grady BE; Spencer JM
    Cutis; 2016 Nov; 98(5):E28-E30. PubMed ID: 28040822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma in situ treated successfully using imiquimod after nonclearance with surgery: review of the literature.
    Ellis LZ; Cohen JL; High W; Stewart L
    Dermatol Surg; 2012 Jun; 38(6):937-46. PubMed ID: 22338583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of persistent melanoma in situ with 5% imiquimod cream.
    Muñoz CM; Sánchez JL; Martín-García RF
    Dermatol Surg; 2004 Dec; 30(12 Pt 2):1543-5. PubMed ID: 15606836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of internal melanoma metastases following application of topical imiquimod to overlying skin.
    Miller AK; Dusing R; Meggison A; Aires D
    J Drugs Dermatol; 2011 Mar; 10(3):302-5. PubMed ID: 21369648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of malignant melanoma in situ with topical 5% imiquimod cream.
    Ray CM; Kluk M; Grin CM; Grant-Kels JM
    Int J Dermatol; 2005 May; 44(5):428-34. PubMed ID: 15869545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
    Fisher GH; Lang PG
    Arch Dermatol; 2003 Jul; 139(7):945-7. PubMed ID: 12873904
    [No Abstract]   [Full Text] [Related]  

  • 10. Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series.
    Rivas-Tolosa N; Ortiz-Brugués A; Toledo-Pastrana T; Baradad M; Traves V; Soriano V; Sanmartín V; Requena C; Martí R; Nagore E
    J Dermatol; 2016 May; 43(5):553-6. PubMed ID: 26660713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.
    Erickson C; Miller SJ
    Int J Dermatol; 2010 May; 49(5):482-91. PubMed ID: 20534080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical imiquimod in the treatment of two cutaneous melanocytomas in a dog.
    Coyner K; Loeffler D
    Vet Dermatol; 2012 Apr; 23(2):145-9, e31. PubMed ID: 21777307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical imiquimod in the treatment of metastatic melanoma to skin.
    Wolf IH; Smolle J; Binder B; Cerroni L; Richtig E; Kerl H
    Arch Dermatol; 2003 Mar; 139(3):273-6. PubMed ID: 12622616
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of imiquimod for residual acral melanoma.
    Sue GR; Hanlon A; Lazova R; Narayan D
    BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25188932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Algorithm for the Management of Residual Head and Neck Melanoma In Situ Using Topical Imiquimod: A Pilot Study.
    Tsay C; Kim S; Norwich-Cavanaugh A; Hsia HC; Narayan D
    Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S199-S201. PubMed ID: 30855388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
    Elfatoiki FZ; Longvert C; Clerici T; Bourgault-Villada I; Roudier-Pujol C; Vasseur E; Saiag P
    Ann Dermatol Venereol; 2014 Feb; 141(2):106-10. PubMed ID: 24507204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcomes of Melanoma In Situ Treated With Topical 5% Imiquimod Cream: A Retrospective Review.
    Park AJ; Paul J; Chapman MS; Samie FH
    Dermatol Surg; 2017 Aug; 43(8):1017-1022. PubMed ID: 28328708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of extensive extramammary Paget disease of the inguinal area to clear with imiquimod cream, 5%: possible progression to invasive disease during therapy.
    Green JS; Burkemper NM; Fosko SW
    Arch Dermatol; 2011 Jun; 147(6):704-8. PubMed ID: 21690533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acral lentiginous melanoma treated with topical imiquimod cream: possible cooperation between drug and tumour cells.
    Savarese I; Papi F; D'Errico A; Gori A; Grazzini M; Vannucchi M; Massi D; De Giorgi V
    Clin Exp Dermatol; 2015 Jan; 40(1):27-30. PubMed ID: 25252087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil].
    Florin V; Vercambre-Darras S; Piette F; Mortier L
    Ann Dermatol Venereol; 2008; 135(8-9):603-4. PubMed ID: 18789300
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.